Revenues were $3.7 million for the period, compared to $3.2 million, an increase of 13.6%, driven by
organic growth and a full quarter with the acquired clinics. Management has continued to show its ability
to consolidate clinics in a fragmented industry and continue to realize growth in revenue, profitability and
economies of scale;
• Gross profit was, $2.6 million for the quarter, compared to $2.1 million, an increase of 22.8%, due to
improvements in capacity utilization, and technology deployment to lower the cost of delivery of services.
Gross margin for Q2 2020 was 70.6% compared with 65.3% for Q2 2019;
• Operating expenses were $2.5 million for the quarter, compared to $3.9 million, a decrease of 34.5%.
Expenses were largely reduced as a result of an overall focus to lower operating costs during the
period, by deploying proprietary technology to optimize workflows, improve patient retention and
automate patient intake and follow-up;
• Significant improvement in Adjusted EBITDA1 gain of $0.37 million, compared to an adjusted EBITDA
loss of $0.79 million and
• Net loss of $0.6 million, compared to $1.8 million achieved through significant improvement in the
operating structure and efficiencies driven through improved processes and technology.
• The Company experienced the first full quarter without a cash burn; resulting in positive cash-flow of
$0.9 million from operations for the half year; and
• A significantly strengthened balance sheet reflected in a cash position of $1.3 million at the end of Q2
2020 and a reduced working capital deficiency of $1.2 million compared to a deficiency of $6.7 million
on December 30, 2019.